Home Biosimilar Antibodies Others Others antibody Lupartumab (Anti-LYPD3 / C4.4A) For research use only.
Not for use in humans.

Lupartumab (Anti-LYPD3 / C4.4A)

Synonyms: BAY 1112623

Lupartumab (Anti-LYPD3 / C4.4A) is an anti-LYPD3 (C4.4A) monoclonal antibody that can be used for the synthesis of the antibody-drug conjugate Lupartumab Amadotin. MW: 145.5 kD.

Lupartumab (Anti-LYPD3 / C4.4A)

Purity & Quality Control

≥99

Biological Activity

Description Lupartumab (Anti-LYPD3 / C4.4A) is an anti-LYPD3 (C4.4A) monoclonal antibody that can be used for the synthesis of the antibody-drug conjugate Lupartumab Amadotin. MW: 145.5 kD.

Product Details

CAS No. 1640971-88-5
Molecular Weight 145.5 kDa
Isotype Human IgG1
Source CHO
Purification AKTA
Sterility 0.2 μM filtered
Formulation 100mMPro-Ac,20mMArg-Ac，pH5.0
Storage
(From the date of receipt)		 Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Lupartumab (Anti-LYPD3 / C4.4A) | Lupartumab (Anti-LYPD3 / C4.4A) supplier | purchase Lupartumab (Anti-LYPD3 / C4.4A) | Lupartumab (Anti-LYPD3 / C4.4A) cost | Lupartumab (Anti-LYPD3 / C4.4A) manufacturer | order Lupartumab (Anti-LYPD3 / C4.4A) | Lupartumab (Anti-LYPD3 / C4.4A) distributor